Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
⏰ React to the Market Faster with Custom, Real-Time News Get Started
Close

Siemens Healthineers AG (SHLd)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
50.58 +0.02    +0.04%
16:21:15 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 1,232
  • Bid/Ask: 50.56 / 51.40
  • Day's Range: 50.26 - 50.78
Type:  Equity
Market:  Euro Zone
ISIN:  DE000SHL1006 
Siemens Healthineers 50.58 +0.02 +0.04%

SHLd Income Statement

 
Assess the Siemens Healthineers AG income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Collapse All
Period Ending: 2022
31/12
 2022
30/09
 2022
30/06
 2022
31/03
Total Revenue 5077 6000 5186 5460
Revenue 5077 6000 5186 5460
Other Revenue, Total - - - -
Cost of Revenue, Total 3220 3678 3317 3421
Gross Profit 1857 2322 1869 2039
Total Operating Expenses 4559 5122 4590 4699
Selling/General/Admin. Expenses, Total 882 939 840 826
Research & Development 441 497 436 444
Depreciation / Amortization 334 -463 343 355
Interest Expense (Income) - Net Operating -45 -37 -32 -24
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -273 508 -314 -323
Operating Income 518 878 596 761
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -
Other, Net 23 18 70 7
Net Income Before Taxes 495 860 526 754
Provision for Income Taxes 70 224 162 170
Net Income After Taxes 425 636 364 584
Minority Interest 14 16 10 8
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 421 631 363 579
Total Extraordinary Items - - - -
Net Income 421 631 363 579
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 421 631 363 579
Dilution Adjustment - -3.22 - -
Diluted Net Income 421 634.22 363 579
Diluted Weighted Average Shares 1137.84 1125 1134.38 1135.29
Diluted EPS Excluding Extraordinary Items 0.37 0.561 0.32 0.51
DPS - Common Stock Primary Issue - 0.95 - -
Diluted Normalized EPS 0.268 0.473 0.289 0.411
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

SHLG Comments

Write your thoughts about Siemens Healthineers AG
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email